Details of the Drug

General Information of Drug (ID: DMDNRU1)

Drug Name
RNS-60
Indication
Disease Entry ICD 11 Status REF
Asthma CA23 Phase 2 [1]
Multiple sclerosis 8A40 Phase 2 [2]
Amyotrophic lateral sclerosis 8B60.0 Phase 1 [2]
Cross-matching ID
TTD ID
D0N9AD
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Heat shock protein 90 (HSP90) TTO7FVG NOUNIPROTAC Modulator [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01714089) Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of Revalesio.